Cellebrite Statements
CL
Data from Cellebrite`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
06 Nov, 2024
Expected release date:
—
Cellebrite Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
106.86
11.6 %
100
15.444
14.5
91.414
15.1 %
85.5
25.926
24.3
46.043
43.1
71.969
7.5 %
67.4
19.445
55.7 %
18.2
-223.98
-209.6
—
0
-204.54
-829.1 %
-191.4
2.556
2.4
-207.09
-769.7 %
-193.8
-0.992
208.71
95.714
6.8 %
100
16.261
17
79.453
4.1 %
83
23.693
24.8
43.273
45.2
66.966
-0.2 %
70
12.487
35 %
13
-34.502
-36.05
—
0
-22.015
68.2 %
-23.0008
1.796
1.9
-23.811
66.6 %
-24.9
-0.12
198.95
89.582
-3.7 %
100
13.264
14.8
76.318
-2.3 %
85.2
23.197
25.9
43.874
49
67.071
6.3 %
74.9
9.247
-38.3 %
10.3
-78.576
-87.7
—
0
-69.329
-461.6 %
-77.4
2.043
2.3
-71.372
-387.3 %
-79.7
-0.363
196.82
93.013
10.5 %
100
14.916
16
78.097
9.5 %
84
21.751
23.4
41.347
44.5
63.098
9.1 %
67.8
14.999
11.3 %
16.1
-27.344
-29.4
—
0
-12.345
-280.2 %
-13.3
2.302
2.5
-14.647
-325.3 %
-15.7
-0.075
194.52
84.179
9.8 %
100
12.878
15.3
71.301
12 %
84.7
20.451
24.3
37.371
44.4
57.822
-2 %
68.7
13.479
191.8 %
16
-6.63
-7.9
—
0
6.849
121.8 %
8.1
0.349
0.4
6.5
120.1 %
7.7
0.032
204.39
76.68
7.7 %
100
13.03
17
63.65
8.2 %
83
21.05
27.5
37.98
49.5
59.03
0.6 %
77
4.62
3200 %
6
-36.05
-47.01
—
0
-31.43
18.7 %
-41
0.92
1.2
-32.35
20.3 %
-42.2
-0.17
188.13
71.23
-3.8 %
100
12.41
17.4
58.83
-4.9 %
82.6
21.13
29.7
37.56
52.7
58.69
12.4 %
82.4
0.14
-98.6 %
0.2
-38.78
-54.4
—
0
-38.64
-524.6 %
-54.2
1.97
2.8
-40.61
-1806.3 %
-57.01
-0.22
186.34
74.02
3.3 %
100
12.13
16.4
61.89
8.3 %
83.6
19.73
26.7
32.48
43.9
52.21
-10.3 %
70.5
9.67
987.2 %
13.1
-0.57
-0.8
—
0
9.1
-62.6 %
12.3
2.02
2.7
2.38
-90.5 %
3.2
0.01
196.67
71.68
14.6 %
100
14.53
20.3
57.14
15.5 %
79.7
21.64
30.2
36.59
51
58.23
5.7 %
81.2
-1.09
80.5 %
-1.5
25.42
35.5
—
0
24.34
-26 %
34
-0.76
-1.06
25.09
-24.4 %
35
0.13
193.19
62.57
0.3 %
100
13.1
20.9
49.48
-3.7 %
79.1
19.68
31.5
35.4
56.6
55.07
3.2 %
88
-5.6
-187.2 %
-8.9
38.47
61.5
—
0
32.87
-39.6 %
52.5
-0.33
-0.5
33.2
-40.1 %
53.1
0.17
192.13
62.39
-8.1 %
100
10.98
17.6
51.4
-7.5 %
82.4
19.58
31.4
33.77
54.1
53.35
4.1 %
85.5
-1.95
-145.2 %
-3.1
56.4
90.4
—
0
54.45
0.6 %
87.3
-0.98
-1.6
55.44
8.9 %
88.9
0.29
188.54
67.91
3.1 %
100
12.34
18.2
55.57
3 %
81.8
18.83
27.7
32.43
47.8
51.26
-10.1 %
75.5
4.31
239.5 %
6.3
49.81
73.3
—
0
54.12
267.7 %
79.7
2.24
3.3
50.91
525.4 %
75
0.27
188.54
65.89
11.4 %
100
11.95
18.1
53.93
9.8 %
81.8
16.43
24.9
40.6
61.6
57.03
39.5 %
86.6
-3.09
-137.6 %
-4.7
17.81
27
—
0
14.72
68.8 %
22.3
6.58
10
8.14
-29.2 %
12.4
0.04
188.54
59.17
11.1 %
100
10.07
17
49.1
8.9 %
83
15.39
26
25.49
43.1
40.88
0.4 %
69.1
8.22
87.2 %
13.9
0.5
0.8
—
0
8.72
83.6 %
14.7
0.92
1.6
11.49
11590 %
19.4
0.06
190.61
53.28
—
100
8.2
15.4
45.08
—
84.6
14.89
27.9
25.8
48.4
40.7
—
76.4
4.39
—
8.2
0.37
0.7
—
0
4.75
—
8.9
1.16
2.2
-0.1
—
-0.2
—
188.54